Evaparin PEN

Evaparin Pen is a prefilled low molecular weight heparin (LMWH) anticoagulant containing the active ingredient Enoxaparin. It is used to treat severe blood clots. This medicine is indicated for prevention of deep vein thrombosis (DVT) following surgeries such as abdominal, hip, and knee replacements, and in patients with reduced mobility during acute illness. It is also used for inpatient and outpatient treatment of acute DVT and for prevention of blood clots in unstable angina and non-Q-wave myocardial infarction. Additionally, it is utilised for treatment of acute ST-segment elevation myocardial infarction, whether managed medically or with percutaneous coronary intervention. It also prevents clot formation within dialysis machine tubes, which is particularly beneficial for patients with significant renal impairment. Do not take Evaparin Pen if you are allergic to Enoxaparin, nadroparin, tinzaparin, dalteparin, benzyl alcohol, pork products, or any other ingredients. Do not take this medicine if you have experienced a severe reduction in clotting cells due to heparin within the last 100 days or have antibodies against the medicine. Avoid use if you are bleeding heavily or at high risk of bleeding from gastric ulcers or recent brain or eye surgery, including bleeding stroke. Do not use this medicine for blood clot treatment if you are to receive spinal or epidural anaesthesia or lumbar puncture within 24 hours. Your healthcare provider will regularly monitor you for signs of bleeding. Inform your doctor if you have been diagnosed with kidney problems. Before using Evaparin Pen, inform your doctor if you experience any severe platelet reduction due to heparin, have a heart valve condition or endocarditis, or have a history of gastric ulcer, recent stroke, high blood pressure, or diabetes with related retinal vessel complications. Notify your doctor if you recently had eye or brain surgery, are 65 years or older, have kidney or liver problems, are under or overweight, or have elevated potassium levels. If you are using medicines affecting bleeding, seek guidance before use. The safety and effectiveness of enoxaparin have not been studied in children or adolescents.

Treat and prevent blood clots.

Evaparin Pen binds to the antithrombin to form a complex. Antithrombin is a protein that blocks the formation of abnormal blood clots. This drug mainly prevents the activation of factor Xa, eventually preventing clot formation.

Evaparin Pen is typically administered by your doctor or nurse through injections. After leaving the hospital, you might need to continue giving injections yourself, following the provided instructions. These medicines are usually injected under the skin (subcutaneous) or, in certain cases of heart attack or surgery, into a vein (intravenous). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.

Side Effects are unwanted symptoms caused by medicines. Although all medicines cause side effects, not everyone gets them. Serious Severe allergic reactions (swelling of lips, tongue, or throat, difficulty breathing, or swallowing) Severe bleeding Blockage of blood vessels Rash of dark red spots under the skin Common Bleeding Bruising more easily Low blood cell counts. Headache Itchy red skin Pain at the injection site Pink patches on the skin

Patients with liver and kidney conditions should take Evaparin Pen cautiously and should inform the doctor about all the underlying medical conditions. Do not stop the medicine until your doctor advises. Notify your doctor if you experience any serious side effects. Your medical professional will inform you if you need any dose adjustments. Contact your doctor for more information. This medicine can cause bleeding and many undesirable side effects. Hence, it is advised to get adequate rest during the treatment. Eat a well-balanced diet. Apply a cool compress at the injection site to reduce pain and irritation.